These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26081252)

  • 21. Evaluation of Adherence to Antiemetic Treatment Guidelines in Patients With Chemotherapy-Induced Nausea and Vomiting in Teaching Hospitals in Tehran.
    Nikbakht Z; Rajabi M; Shahrasbi A; Roohi E; Hashemian F
    J Cancer Educ; 2021 Oct; 36(5):1022-1029. PubMed ID: 31955393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of nausea and vomiting with 5HT3 receptor antagonists, steroids, antihistamines, anticholinergics, somatostatinantagonists, benzodiazepines and cannabinoids in palliative care patients : a systematic review].
    Benze G; Geyer A; Alt-Epping B; Nauck F
    Schmerz; 2012 Sep; 26(5):481-99. PubMed ID: 22983450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assuring the optimal use of serotonin antagonist antiemetics: the process for development and implementation of institutional antiemetic guidelines at Memorial Sloan-Kettering Cancer Center.
    Nolte MJ; Berkery R; Pizzo B; Baltzer L; Grossano D; Lucarelli CD; Kris MG
    J Clin Oncol; 1998 Feb; 16(2):771-8. PubMed ID: 9469369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiation-induced nausea and vomiting: a comparison between MASCC/ESMO, ASCO, and NCCN antiemetic guidelines.
    McKenzie E; Zaki P; Raman S; Olson R; McFarlane T; DeAngelis C; Chan S; Pidduck W; Razvi Y; Bushehri A; Chow E
    Support Care Cancer; 2019 Mar; 27(3):783-791. PubMed ID: 30607675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adherence to antiemetic guidelines in patients with malignant glioma: a quality improvement project to translate evidence into practice.
    Affronti ML; Schneider SM; Herndon JE; Schlundt S; Friedman HS
    Support Care Cancer; 2014 Jul; 22(7):1897-905. PubMed ID: 24570103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent Advances in Antiemetics: New Formulations of 5-HT3 Receptor Antagonists in Adults.
    Smith C; Smith M; Cunningham R; Davis S
    Cancer Nurs; 2020; 43(4):E217-E228. PubMed ID: 30688665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The survey for anti-emetic guideline by using questioner].
    Saeki T; Tamura K; Aiba K; Aogi K; Iino K; Imamura C; Eguchi K; Okita K; Kagami Y; Tanaka R; Nakagawa K; Fujii H; Boku N; Matsuura K; Wada M; Akechi T; Kakudo Y; Kim YI; Sasaki H; Shima Y; Takeda M; Nagasaki E; Nishidate T; Saito M; Ashikaga Y; Tanigawara Y; Hirata K; Ishioka C; Nishiyama M
    Gan To Kagaku Ryoho; 2015 Mar; 42(3):305-11. PubMed ID: 25812498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations.
    Jordan K; Sippel C; Schmoll HJ
    Oncologist; 2007 Sep; 12(9):1143-50. PubMed ID: 17914084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prophylaxis of chemotherapy-induced vomiting and nausea].
    Tóth J; Szántó J
    Magy Onkol; 2008 Dec; 52(4):391-4. PubMed ID: 19068468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. International antiemetic guidelines on chemotherapy induced nausea and vomiting (CINV): content and implementation in daily routine practice.
    Jordan K; Gralla R; Jahn F; Molassiotis A
    Eur J Pharmacol; 2014 Jan; 722():197-202. PubMed ID: 24157984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.
    ; Kris MG; Hesketh PJ; Somerfield MR; Feyer P; Clark-Snow R; Koeller JM; Morrow GR; Chinnery LW; Chesney MJ; Gralla RJ; Grunberg SM
    J Clin Oncol; 2006 Jun; 24(18):2932-47. PubMed ID: 16717289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of antiemetics in the management of chemotherapy-related nausea and vomiting in current UK practice.
    Molassiotis A; Brearley SG; Stamataki Z
    Support Care Cancer; 2011 Jul; 19(7):949-56. PubMed ID: 20574666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimizing emetic control in children receiving antineoplastic therapy: beyond the guidelines.
    Dupuis LL; Nathan PC
    Paediatr Drugs; 2010; 12(1):51-61. PubMed ID: 20034341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of dexamethasone with 5-HT3-receptor antagonists for chemotherapy-induced nausea and vomiting.
    Perez EA
    Cancer J Sci Am; 1998; 4(2):72-7. PubMed ID: 9532406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multi-institutional survey of antiemetic therapy in lung cancer patients treated with carboplatin in Hokushin region.
    Ide T; Nishino Y; Takiguchi T; Kanda S; Otsuki K; Hayashi R; Yasumoto K; Hirono Y; Makino T; Yano S; Koizumi T
    BMC Pulm Med; 2023 Jun; 23(1):228. PubMed ID: 37365528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapy.
    Kris MG; Hesketh PJ; Herrstedt J; Rittenberg C; Einhorn LH; Grunberg S; Koeller J; Olver I; Borjeson S; Ballatori E
    Support Care Cancer; 2005 Feb; 13(2):85-96. PubMed ID: 15565277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical roundtable monograph. Treatment of chemotherapy-induced nausea and vomiting: a post-MASCC 2010 discussion.
    Kris MG; Urba SG; Schwartzberg LS
    Clin Adv Hematol Oncol; 2011 Jan; 9(1):suppl 1-15. PubMed ID: 21370520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study protocol for a double-blind, comparative, randomised Japanese trial of triplet standard antiemetic therapies with or without 5 mg olanzapine to prevent chemotherapy-induced nausea and vomiting for patients with breast cancer treated with an anthracycline/cyclophosphamide regimen (JTOP-B).
    Ozeki R; Iihara H; Shimokawa M; Hashimoto H; Abe M; Mukohara T; Bando H; Hayashi T; Kawazoe H; Komoda M; Yanai Takahashi T; Saito M
    BMJ Open; 2022 Mar; 12(3):e058755. PubMed ID: 35236735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients.
    Navari RM
    Paediatr Drugs; 2017 Jun; 19(3):213-222. PubMed ID: 28447301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of Antiemetic Regimens for Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Network Meta-Analysis.
    Yokoe T; Hayashida T; Nagayama A; Nakashoji A; Maeda H; Seki T; Takahashi M; Takano T; Abe T; Kitagawa Y
    Oncologist; 2019 Jun; 24(6):e347-e357. PubMed ID: 30333194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.